Results 181 to 190 of about 42,064 (302)

Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland [PDF]

, 2007
Lisa Devlin, Charles Shepherd, Harriet Crawford, Patrick J. Morrison   +3 more
openalex   +1 more source

RHEB1 Expression in Embryonic and Postnatal Mouse

, 2016
Ras homolog enriched in brain (RHEB1) is a member within the superfamily of GTP-binding proteins encoded by the RAS oncogenes. RHEB1 is located at the crossroad of several important pathways including the insulin-signaling pathways and thus plays an ...
Clement, Joachim H, Danilchik, Michael V., Derkatch, Alex, Federov, Lev M., Marks, Daniel L., Schubert, Harald, Smart, James L., Tian, Qi, Wang, Yingming   +8 more
core  

Cerebral Cavernous Malformations and Focal Drug‐Resistant Epilepsy: Behind a Quid Pro Quo of Lesion and Epileptogenic Networks

European Journal of Neurology, Volume 32, Issue 7, July 2025.
ABSTRACT Background Cerebral cavernous malformations (CCMs) contribute to focal drug‐resistant epilepsy (fDRE), with surgical outcomes varying due to an incomplete understanding of the interplay between CCM‐impacted regions and areas exhibiting ictal or interictal epileptogenicity.
Ionuț‐Flavius Bratu, Lucie de Clerck, Hélène Catenoix, Luc Valton, Jérôme Aupy, Anca Nica, Sylvain Rheims, Sandrine Aubert‐Conil, Jeanne Benoit, Julia Makhalova, Ophélie Galli, Samuel Medina Villalon, Fabrice Bartolomei   +12 more
wiley   +1 more source

Tuberous Sclerosis Complex-Associated Tubulointerstitial Kidney Disease. [PDF]

Kidney Int Rep
Sakhi H, Isnard P, Boudhabhay I, Correas JM, Burtey S, Joly D, Knebelmann B, Servais A.   +7 more
europepmc   +1 more source

The Correlation between ¹H-MR Spectroscopy and Clinical Manifestation with Tuberous Sclerosis Complex [PDF]

, 2007
Nanae Matsuo, Atsushi Imamura, Reiji Ito, K. Sugawara, Yukitoshi Takahashi, Naoya Kondo   +5 more
openalex   +1 more source

ApoE Inhibits the Progression of Glioma by Activating Immune Function

Journal of Cellular and Molecular Medicine, Volume 29, Issue 13, July 2025.
ABSTRACT Glioma, marked by a low mutational burden, low immunogenicity, high heterogeneity, and the challenges posed by the blood–brain barrier, continues to be a major hurdle in neuro‐oncology. Current research underscores the necessity for more effective medications and treatment strategies.
Xiao‐fei Liu, Yu‐jie Chang, Min Long, Kai‐qi Huang, Bing Wang, Duo Gong, Jun‐Li Luo, Yong Feng   +7 more
wiley   +1 more source

A bitopic mTORC inhibitor reverses phenotypes in a tuberous sclerosis complex model. [PDF]

Sci Rep
Mukherjee S, Wolan MJ, Scott MK, Riley VA, Sokolov AM, Feliciano DM.   +5 more
europepmc   +1 more source

Can Preventative Antiepileptic Therapy Alter Outcome in Infants with Tuberous Sclerosis Complex? [PDF]

, 2007
Carl E. Stafstrom, Gregory L. Holmes
openalex   +1 more source

A 24-year-Old woman with recurrent pneumothoraces

Respiratory Medicine Case Reports
Lymphangioleiomyomatosis (LAM) is an abnormal proliferation of smooth muscle-like cells and may occur sporadically or in association with tuberous sclerosis complex.
Daniel J. Greenberg, Anuraag Sah, Amit Chopra, Nagendra Madisi   +3 more
doaj  

Blood Biomarkers to Identify Renal Angiomyolipomas in People With Tuberous Sclerosis Complex. [PDF]

Neurol Genet
Balthazard R, Li J, Loubert F, Drouin-Engler RM, Boisclair M, Coquelet P, Nguyen A, Rebillard RM, Arbour N, Major P, House AA, Larochelle C, Keezer MR.   +12 more
europepmc   +1 more source